Guideline Central
Clinical Guideline InSights
Quick rapid summaries highlighting the latest guideline recommendations and updates published by medical societies.https://www.guidelinecentral.com/
No dejes de visitar la web del podcast y apoyar a su creador: www.guidelinecentral.com
Autor
Guideline Central
Categoría
Web del podcast
Último episodio
9 de jul. de 2026
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Episodios
ASCO Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Update – Key Changes 11.03.2026 5:02
A rapid update of the 2026 Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer guideline, highlighting key updates across recommendations on predictive biomarker testing, first-line therapy, and second- or third-line therapyImmunotherapy and Targeted Therapy for Advanced Gastroesophageal CancerAmerican Society of Clinical OncologyFebruary 26th, 2026Guideline Summary: https://ww...
AUA/SUO Early Detection of Prostate Cancer Update –Key Changes for Initial/Repeat Biopsy & Technique 11.03.2026 1:30
A rapid update of the 2026 AUA/SUO Early Detection of Prostate Cancer guideline update, highlighting key changes for initial/repeat biopsy & techniqueEarly Detection of Prostate CancerAmerican Urological Association & Society of Urologic OncologyFebruary 25th, 2026Guideline Summary: https://www.guidelinecentral.com/guideline/2735995/Full-Text: https://www.auanet.org/guidelines-and-quality/...
Weekly Guideline Recap 3/2/2026 – New Guidelines & Consensus Statements from ASCO, AHA, DHHS & more 02.03.2026 1:25
A weekly guideline recap with guideline and consensus statement updates from ASCO, AUA/SUO, DHHS, EHRE, AHA, & ISHLT. https://www.guidelinecentral.com/guidelines/
Weekly Medication Recap 3/2/2026 – New FDA approvals for Dupixent, Hernexeos, Desmoda & more 02.03.2026 1:48
A weekly medication recap going over new FDA medication approvals and indications for Loargys, Dupixent, Desmoda, Hernexeos, Yuviwell, and Sogroya https://www.guidelinecentral.com/drugs/
ASH Management of Relapsed/Refractory Disease in AYAs with Acute Lymphoblastic Leukemia – Overview 02.03.2026 2:07
An update of the 2026 ASH Management of Relapsed/Refractory Disease in Adolescents and Young Adults with Acute Lymphoblastic Leukemia guideline, published by the American Society of Hematology on February 11, 2026. Guideline Summary: https://www.guidelinecentral.com/guideline/5084999/ Full-Text: https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2021006479/566562/ASH-2026-...
ACC/AHA Evaluation and Management of Acute Pulmonary Embolism in Adults - Key Messages 02.03.2026 2:58
A rapid update of the 2026 Evaluation and Management of Acute Pulmonary Embolism in Adults guideline from the American College of Cardiology/American Heart Association, highlighting 10 top take-home messages. The guideline provides comprehensive recommendations for the evaluation, management, and follow-up of adult patients with acute pulmonary embolism. Guideline Summary: https://www.guidelinecen...
Podcasts similares
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos